Published on
Apr 11, 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple ...
Introduction Multiple sclerosis (MS) is a chronic disease affecting the central nervous system that represents the leading cause of non-traumatic neurological disability in young adult people. In Italy, the prevalence and incidence of MS were estimated to …
Source:
Dove Medical Press
-
Neutral
